Market Research Report

Small Molecule Drug CDMO Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-19440
  • CAT ID : 7
  • Pages : 136
  • Date : Jun 2023
 

The global Small Molecule Drug CDMO market was valued at US$ 28650 million in 2022 and is projected to reach US$ 42080 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
FDF CDMO Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Drug CDMO include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried and FUJIFILM Diosynth Biotechnologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMO. This report contains market size and forecasts of Small Molecule Drug CDMO in global, including the following market information:
Global Small Molecule Drug CDMO Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule Drug CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Drug CDMO Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Small Molecule Drug CDMO Market Segment Percentages, by Type, 2022 (%)
FDF CDMO
Packaging CDMO
Clinical CDMO
Global Small Molecule Drug CDMO Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Small Molecule Drug CDMO Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Company
Biotechnology Company
Other
Global Small Molecule Drug CDMO Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Small Molecule Drug CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Drug CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Small Molecule Drug CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Drug CDMO, market overview.
Chapter 2: Global Small Molecule Drug CDMO market size in revenue.
Chapter 3: Detailed analysis of Small Molecule Drug CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Drug CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Small Molecule Drug CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Drug CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Drug CDMO Overall Market Size
2.1 Global Small Molecule Drug CDMO Market Size: 2022 VS 2029
2.2 Global Small Molecule Drug CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Drug CDMO Players in Global Market
3.2 Top Global Small Molecule Drug CDMO Companies Ranked by Revenue
3.3 Global Small Molecule Drug CDMO Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Drug CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Molecule Drug CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Drug CDMO Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Drug CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Drug CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Small Molecule Drug CDMO Market Size Markets, 2022 & 2029
4.1.2 FDF CDMO
4.1.3 Packaging CDMO
4.1.4 Clinical CDMO
4.2 By Type - Global Small Molecule Drug CDMO Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Drug CDMO Revenue, 2018-2023
4.2.2 By Type - Global Small Molecule Drug CDMO Revenue, 2024-2029
4.2.3 By Type - Global Small Molecule Drug CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Drug CDMO Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Biotechnology Company
5.1.4 Other
5.2 By Application - Global Small Molecule Drug CDMO Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Drug CDMO Revenue, 2018-2023
5.2.2 By Application - Global Small Molecule Drug CDMO Revenue, 2024-2029
5.2.3 By Application - Global Small Molecule Drug CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Small Molecule Drug CDMO Market Size, 2022 & 2029
6.2 By Region - Global Small Molecule Drug CDMO Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Drug CDMO Revenue, 2018-2023
6.2.2 By Region - Global Small Molecule Drug CDMO Revenue, 2024-2029
6.2.3 By Region - Global Small Molecule Drug CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Small Molecule Drug CDMO Revenue, 2018-2029
6.3.2 US Small Molecule Drug CDMO Market Size, 2018-2029
6.3.3 Canada Small Molecule Drug CDMO Market Size, 2018-2029
6.3.4 Mexico Small Molecule Drug CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Small Molecule Drug CDMO Revenue, 2018-2029
6.4.2 Germany Small Molecule Drug CDMO Market Size, 2018-2029
6.4.3 France Small Molecule Drug CDMO Market Size, 2018-2029
6.4.4 U.K. Small Molecule Drug CDMO Market Size, 2018-2029
6.4.5 Italy Small Molecule Drug CDMO Market Size, 2018-2029
6.4.6 Russia Small Molecule Drug CDMO Market Size, 2018-2029
6.4.7 Nordic Countries Small Molecule Drug CDMO Market Size, 2018-2029
6.4.8 Benelux Small Molecule Drug CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Small Molecule Drug CDMO Revenue, 2018-2029
6.5.2 China Small Molecule Drug CDMO Market Size, 2018-2029
6.5.3 Japan Small Molecule Drug CDMO Market Size, 2018-2029
6.5.4 South Korea Small Molecule Drug CDMO Market Size, 2018-2029
6.5.5 Southeast Asia Small Molecule Drug CDMO Market Size, 2018-2029
6.5.6 India Small Molecule Drug CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Small Molecule Drug CDMO Revenue, 2018-2029
6.6.2 Brazil Small Molecule Drug CDMO Market Size, 2018-2029
6.6.3 Argentina Small Molecule Drug CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Drug CDMO Revenue, 2018-2029
6.7.2 Turkey Small Molecule Drug CDMO Market Size, 2018-2029
6.7.3 Israel Small Molecule Drug CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia Small Molecule Drug CDMO Market Size, 2018-2029
6.7.5 UAE Small Molecule Drug CDMO Market Size, 2018-2029
7 Small Molecule Drug CDMO Companies Profiles
7.1 Lonza
7.1.1 Lonza Company Summary
7.1.2 Lonza Business Overview
7.1.3 Lonza Small Molecule Drug CDMO Major Product Offerings
7.1.4 Lonza Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.1.5 Lonza Key News & Latest Developments
7.2 Catalent
7.2.1 Catalent Company Summary
7.2.2 Catalent Business Overview
7.2.3 Catalent Small Molecule Drug CDMO Major Product Offerings
7.2.4 Catalent Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.2.5 Catalent Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Major Product Offerings
7.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Samsung Biologics
7.4.1 Samsung Biologics Company Summary
7.4.2 Samsung Biologics Business Overview
7.4.3 Samsung Biologics Small Molecule Drug CDMO Major Product Offerings
7.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.4.5 Samsung Biologics Key News & Latest Developments
7.5 Fareva
7.5.1 Fareva Company Summary
7.5.2 Fareva Business Overview
7.5.3 Fareva Small Molecule Drug CDMO Major Product Offerings
7.5.4 Fareva Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.5.5 Fareva Key News & Latest Developments
7.6 WuXi AppTech
7.6.1 WuXi AppTech Company Summary
7.6.2 WuXi AppTech Business Overview
7.6.3 WuXi AppTech Small Molecule Drug CDMO Major Product Offerings
7.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTech Key News & Latest Developments
7.7 WuXi Biologics
7.7.1 WuXi Biologics Company Summary
7.7.2 WuXi Biologics Business Overview
7.7.3 WuXi Biologics Small Molecule Drug CDMO Major Product Offerings
7.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.7.5 WuXi Biologics Key News & Latest Developments
7.8 Siegfried
7.8.1 Siegfried Company Summary
7.8.2 Siegfried Business Overview
7.8.3 Siegfried Small Molecule Drug CDMO Major Product Offerings
7.8.4 Siegfried Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.8.5 Siegfried Key News & Latest Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Major Product Offerings
7.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.10 Asymchem
7.10.1 Asymchem Company Summary
7.10.2 Asymchem Business Overview
7.10.3 Asymchem Small Molecule Drug CDMO Major Product Offerings
7.10.4 Asymchem Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.10.5 Asymchem Key News & Latest Developments
7.11 Pfizer CentreOne
7.11.1 Pfizer CentreOne Company Summary
7.11.2 Pfizer CentreOne Business Overview
7.11.3 Pfizer CentreOne Small Molecule Drug CDMO Major Product Offerings
7.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.11.5 Pfizer CentreOne Key News & Latest Developments
7.12 Delpharm
7.12.1 Delpharm Company Summary
7.12.2 Delpharm Business Overview
7.12.3 Delpharm Small Molecule Drug CDMO Major Product Offerings
7.12.4 Delpharm Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.12.5 Delpharm Key News & Latest Developments
7.13 Recipharm
7.13.1 Recipharm Company Summary
7.13.2 Recipharm Business Overview
7.13.3 Recipharm Small Molecule Drug CDMO Major Product Offerings
7.13.4 Recipharm Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.13.5 Recipharm Key News & Latest Developments
7.14 AGC Pharma Chemicals
7.14.1 AGC Pharma Chemicals Company Summary
7.14.2 AGC Pharma Chemicals Business Overview
7.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Major Product Offerings
7.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.14.5 AGC Pharma Chemicals Key News & Latest Developments
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Company Summary
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Major Product Offerings
7.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.15.5 Boehringer Ingelheim Key News & Latest Developments
7.16 Vetter
7.16.1 Vetter Company Summary
7.16.2 Vetter Business Overview
7.16.3 Vetter Small Molecule Drug CDMO Major Product Offerings
7.16.4 Vetter Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.16.5 Vetter Key News & Latest Developments
7.17 Curia
7.17.1 Curia Company Summary
7.17.2 Curia Business Overview
7.17.3 Curia Small Molecule Drug CDMO Major Product Offerings
7.17.4 Curia Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.17.5 Curia Key News & Latest Developments
7.18 Aenova
7.18.1 Aenova Company Summary
7.18.2 Aenova Business Overview
7.18.3 Aenova Small Molecule Drug CDMO Major Product Offerings
7.18.4 Aenova Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.18.5 Aenova Key News & Latest Developments
7.19 Porton
7.19.1 Porton Company Summary
7.19.2 Porton Business Overview
7.19.3 Porton Small Molecule Drug CDMO Major Product Offerings
7.19.4 Porton Small Molecule Drug CDMO Revenue in Global Market (2018-2023)
7.19.5 Porton Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe